Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2352 (LINC02352) is part of a broad genomic class of long intergenic non-coding RNAs, non-protein coding transcripts longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs can regulate gene expression, remodel chromatin, serve as scaffolds for protein complexes, and modulate RNA stability and transcriptional programs, often in a tissue- or context-specific manner. Only a minority of lincRNAs have been functionally characterized, and there is limited specific information about the function or disease association of LINC02352 itself in current scientific databases. Overall, while lincRNAs, including LINC02352, play important roles in cellular regulatory networks, LINC02352 has not been recognized as a direct therapeutic target or biomarker based on currently available evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2352 (LINC02352).